Pustular Psoriasis Latest Advances

Rapid resolution of generalized pustular psoriasis with upadacitinib.

Journal: JAAD case reports

Published: August 09, 2026

INDIVIDUAL ARTICLE: Generalized Pustular Psoriasis: A Contemporary Review of Diagnosis, Pathophysiology, and IL-36 Pathway-Directed Management.

Journal: Journal of drugs in dermatology : JDD

Published: August 05, 2026

Deucravacitinib for Generalized Pustular Psoriasis and Comorbid Polymyositis: Dual Efficacy and Favorable Safety.

Journal: American journal of therapeutics

Published: June 29, 2026

Comment on 'Clinical phenotype of 504 pustular psoriasis patients from Europe and Egypt: a multi-center observational study'.

Journal: Clinical and experimental dermatology

Published: June 25, 2026

Extensive Pustular Tinea Incognita During Late Pregnancy: A Case Report.

Journal: Cureus

Published: June 21, 2026

Early Temporal Dissociation Between C-Reactive Protein and Neutrophil Counts After Spesolimab Treatment in Generalized Pustular Psoriasis.

Journal: Acta dermato-venereologica

Published: June 19, 2026

SAPHO syndrome and pustular skin diseases: shared inflammatory circuits, divergent tissue outcomes, and the limits of a spectrum model.

Journal: Frontiers in immunology

Published: June 11, 2026

Recurrent pustular psoriasis of pregnancy and postpartum flare.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Published: June 08, 2026

Paradoxical pustular psoriasis following dupilumab therapy for bullous pemphigoid: A case report.

Journal: JAAD case reports

Published: May 22, 2026

Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial.

Journal: The British journal of dermatology

Published: May 21, 2026

Treatment Patterns and Pathways of Systemic Drug Therapy in Patients With Plaque, Erythrodermic, and Generalized Pustular Psoriasis: A Retrospective Cohort Study in Japan.

Journal: The Journal of dermatology

Published: May 15, 2026

Efficacy and safety of Janus kinase and TYK2 inhibitors in the treatment of generalized pustular psoriasis and palmoplantar pustulosis: a systematic review.

Journal: Immunologic research

Published: May 10, 2026

Pustular Psoriasis Latest Advances

Find the Latest Research About Pustular Psoriasis

Rapid resolution of generalized pustular psoriasis with upadacitinib.

Rapid resolution of generalized pustular psoriasis with upadacitinib.

INDIVIDUAL ARTICLE: Generalized Pustular Psoriasis: A Contemporary Review of Diagnosis, Pathophysiology, and IL-36 Pathway-Directed Management.

INDIVIDUAL ARTICLE: Generalized Pustular Psoriasis: A Contemporary Review of Diagnosis, Pathophysiology, and IL-36 Pathway-Directed Management.

Deucravacitinib for Generalized Pustular Psoriasis and Comorbid Polymyositis: Dual Efficacy and Favorable Safety.

Deucravacitinib for Generalized Pustular Psoriasis and Comorbid Polymyositis: Dual Efficacy and Favorable Safety.

Comment on 'Clinical phenotype of 504 pustular psoriasis patients from Europe and Egypt: a multi-center observational study'.

Comment on 'Clinical phenotype of 504 pustular psoriasis patients from Europe and Egypt: a multi-center observational study'.

Extensive Pustular Tinea Incognita During Late Pregnancy: A Case Report.

Extensive Pustular Tinea Incognita During Late Pregnancy: A Case Report.

Early Temporal Dissociation Between C-Reactive Protein and Neutrophil Counts After Spesolimab Treatment in Generalized Pustular Psoriasis.

Early Temporal Dissociation Between C-Reactive Protein and Neutrophil Counts After Spesolimab Treatment in Generalized Pustular Psoriasis.

SAPHO syndrome and pustular skin diseases: shared inflammatory circuits, divergent tissue outcomes, and the limits of a spectrum model.

SAPHO syndrome and pustular skin diseases: shared inflammatory circuits, divergent tissue outcomes, and the limits of a spectrum model.

Recurrent pustular psoriasis of pregnancy and postpartum flare.

Recurrent pustular psoriasis of pregnancy and postpartum flare.

Paradoxical pustular psoriasis following dupilumab therapy for bullous pemphigoid: A case report.

Paradoxical pustular psoriasis following dupilumab therapy for bullous pemphigoid: A case report.

Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial.

Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial.

Treatment Patterns and Pathways of Systemic Drug Therapy in Patients With Plaque, Erythrodermic, and Generalized Pustular Psoriasis: A Retrospective Cohort Study in Japan.

Treatment Patterns and Pathways of Systemic Drug Therapy in Patients With Plaque, Erythrodermic, and Generalized Pustular Psoriasis: A Retrospective Cohort Study in Japan.

Efficacy and safety of Janus kinase and TYK2 inhibitors in the treatment of generalized pustular psoriasis and palmoplantar pustulosis: a systematic review.

Efficacy and safety of Janus kinase and TYK2 inhibitors in the treatment of generalized pustular psoriasis and palmoplantar pustulosis: a systematic review.